Education
About Us
Working with TipRanks
Follow Us
My Biotech Portfolio - New Portfolio
Grant Jiao
My Biotech PortfolioIndividual Investor
Ranked #654,025 out of 799,702 TipRanks' Investors
Success Rate
69 out of 208
profitable transactions
profitable transactions
Average Return
-24.50%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 8.25%
6-Month Return▲ 15.26%
12-Month Return▲ 5.25%
YTD Return▲ 4.55%
Total Return▼ 24.97%
Best Trade
Bio
Focus on breakthrough biotech companies with long term appreciation opportunities
Performance
27.22%0-27.22%
▲ 9.99%
▼ 0.89%
▼ 2.43%
Oct 2024
▲ 25.97%
▲ 5.96%
▼ 0.76%
Nov 2024
▲ 5.41%
▼ 2.41%
▲ 5.89%
Dec 2024
▲ 6.02%
▲ 2.69%
▲ 27.22%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 10.34%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 5.69%
Mar 2025
▲ 1.73%
▼ 0.87%
▲ 5.50%
Apr 2025
▲ 14.05%
▲ 6.48%
▼ 7.88%
May 2025
▲ 9.99%▼ 0.89%▼ 2.43%
▲ 25.97%▲ 5.96%▼ 0.76%
▲ 5.41%▼ 2.41%▲ 5.89%
▲ 6.02%▲ 2.69%▲ 27.22%
▼ 12.86%▼ 1.27%▼ 10.34%
▼ 1.80%▼ 5.57%▼ 5.69%
▲ 1.73%▼ 0.87%▲ 5.50%
▲ 14.05%▲ 6.48%▼ 7.88%
Recent Activity
Intra-Cellular Therapies
―
▲ 362.48%
8
Close
Apr 01, 2025
Marinus
―
▼ 96.03%
5
Close
Feb 10, 2025
Oncternal Therapeutics
―
▼ 99.53%
5
Close
Dec 02, 2024
TRACON Pharmaceuticals
―
▼ 37.40%
5
Close
Dec 02, 2024
Gamida Cell
―
▼ 99.83%
4
Close
May 24, 2024
Sio Gene Therapies
―
▼ 54.15%
5
Close
Feb 07, 2024
Zynerba Pharmaceuticals
―
▼ 65.80%
5
Close
Oct 10, 2023
Coherus Biosciences
0.29%
▼ 54.83%
4
Buy
Sep 11, 2023
Surface Oncology
―
▼ 87.14%
7
Close
Sep 11, 2023
Applied Genetic Technologies
―
▼ 92.22%
9
Close
Nov 30, 2022
Corvus Pharmaceuticals
0%
▼ 41.49%
1
Open
Sep 18, 2021
Palantir Technologies
0%
▲ 406.33%
1
Open
Sep 08, 2021
Atossa Therapeutics
0%
▼ 76.17%
1
Open
Jun 10, 2021
Ardelyx
0.12%
▼ 44.33%
2
Sell
Mar 20, 2021
Mirum Pharmaceuticals
13.98%
▲ 140.33%
7
Sell
Mar 20, 2021
Zevra Therapeutics
2.69%
▲ 20.42%
7
Sell
Mar 20, 2021
Curis
0.13%
▼ 92.83%
6
Sell
Mar 20, 2021
Carisma Therapeutics
0.05%
▼ 99.18%
6
Sell
Mar 20, 2021
Iovance Biotherapeutics
0.64%
▼ 95.35%
6
Sell
Mar 20, 2021
Altimmune
1.73%
▼ 59.42%
9
Sell
Mar 20, 2021